Phosphonated n,o-nucleosides: Synthesis and biological evaluation

Mini-Reviews in Organic Chemistry

Volumn 12, Issue 3, 2015, Pages 249-257

  Giofrè, Salvatore V ^a   Romeo, Roberto ^a   Chiacchio, Ugo ^b   Romeo, Giovanni ^a   Chiacchio, Maria A ^b  

^a Dipartimento di Scienze Del Farmaco e Dei Prodotti per la Salute   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

1; 3 dipolar cycloaddition; Antitumor agents; Antiviral agents; Biological tests; Nitrones; Onucleosides; Phosphonated N; Synthesis

Indexed keywords

ANTIVIRAL AGENTS; CYCLOADDITION;

3-DIPOLAR CYCLOADDITION; ANTITUMOUR AGENTS; BIOLOGICAL EVALUATION; BIOLOGICAL TESTS; NITRONES; NUCLEOSIDE SYNTHESIS; ONUCLEOSIDE; ORTHOGONAL SPACE-TIME BLOCK CODED SYSTEMS; PHOSPHONATED N; SYNTHESIS EVALUATION;

BIOMOLECULES;

EID: 84929611411     PISSN: 1570193X     EISSN: 18756298     Source Type: Journal    
DOI: 10.2174/1570193x1203150429104924     Document Type: Article

References (82)

1. Parker, W.B. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem. Rev., 2009, 109, 2880-2893
2. Liu, G.; Pranssen, E.; Fitch, E.F.; Warnew, E. Patient preferences for oral versus intravenous palliative chemotherapy. J. Clin. Oncol., 1997, 15, 110-115
3. Hishitsuka, H.; Shimma, N. In: Modified Nucleosides in Biochemistry, Biotechnology and Medicine. Herdewijn, P., Ed., Wiley, 2008, pp. 587-600
4. Takahashi, T.; Shimuzu, M.; Akinaga, S. Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEM. Cancer Chemother. Pharmacol., 2002, 50(3), 193-201
5. Thottassery, J.V.; Westbrook, L.; Someya, H.; Parker, W.B. c-Abl-independent p73 stabilization during gemcitabine- or 4'-thio-beta-Darabinofuranosylcytosine- induced apoptosis in wild-type and p53- null colorectal cancer cells. Mol. Cancer Ther., 2006, 5, 400-410
6. Miura, S.; Izuta, S. DNA polymerases as targets of anticancer nucleosides. Curr. Drug Targets, 2004, 5, 191-195
7. Klopfer, A.; Hasenjager, A.; Belka, C.; Schulze-Osthoff, K.; Dorken, B.; Daniel, P.T. Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8- independent manner by activation of the mitochondrial cell death pathway. Oncogene, 2004, 23, 9408-9418
8. De Clercq, E. The history of antiretrovirals: key discoveries over the past 25 years. Rev. Med. Virol. 2009, 19, 287-299
9. De Clercq, E. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge. Biochem. Pharmacol., 2007, 73, 911-922
10. Cihlar, T.; LaFlamme, G.; Fisher, R.; Carey, A.C.; Vela, J.E.; Mackman, R.; Ray, A.S. Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. Antimicrob. Agents Chemother., 2009, 53, 150-156
11. Choo, H.; Beadle, J.R.; Kern, E.R.; Prichard, M.N.; Keith, K.A.; Hartlina, C.B.; Trahan, J.; Aldern, K.A.; Korba, B.E.; Hostetler, K.Y. Antiviral activities of novel 5- phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters. Antimicrob. Agents Chemother., 2007, 51, 611-615
12. Krcmerova, M.; Holy, A.; Piskala, A.; Masojidkova, M.; Andrei, G.; Naesens, L.; Neyts, J.; Balzarini, J.; De Clercq, E.; Snoeck, R. Antiviral activity of triazine analogues of 1-(S)-[3-hydroxy-2- (phosphonomethoxy)propyl]cytosine (cidofovir) and related compounds. J. Med. Chem. 2007, 50, 1069-1077
13. Lebeau, I.; Andrei, G.; Krecmerova, M.; De Clercq, E.; Holy, A; Snoeck, R. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains. Antimicrob. Agent Chemother., 2007, 51, 2268-2273
14. Vanek, V.; Budesinsky, M.; Rinnova, M.; Rosemberg, I. Prolinol- based nucleoside phosphonic acids: new isosteric conformationally flexible nucleotide analogues. Tetrahedron, 2009, 65, 862-876
15. Kumamoto, H.; Topalis, D.; Broggi, J.; Pradere, U.; Roi, V.; Berteina-Raboin, S.; Nolan, S.P.; Deville-Bonne, D.; Andrei, G.; Snoeck, R.; Garin, D.; Grance, G.M.; Agrofoglio, L.A. Preparation of acyclo nucleoside phosphonate analogues based on crossmetathesis. Tetrahedron, 2008, 64, 3517-3526
16. Vrbkova, S.; Dracinsky, M.; Holy, A. Synthesis of phosphonomethoxyethyl or 1,3-bis(phosphonomethoxy)propan-2-yl lipophilic esters of acyclic nucleoside Phosphonates. Tetrahedron, 2007, 63, 11391-11398
17. Romeo G.; Chiacchio U.; Corsaro, A.; Merino, P. Chemical synthesis of heterocyclic-sugar nucleoside analogues. Chem. Rev., 2010, 110, 3337-3370
18. Merino, P. Heterocyclic nucleosides: chemical synthesis and biological properties. Curr. Med. Chem., 2006, 13, 539-545
19. Wang, J.; Rawal, R.K.; Chu, C.K. Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity. In: Zhang, L.H.; Xi, Z.; Chattopadhyaya, J., Eds., Med. Chem. Nucleic Acids, 2011, pp. 1-100
20. Gundersen, L. Metal-mediated C-C and C-N bond formation in the synthesis of bioactive purines. Targets Heterocycl. Syst., 2008, 12, 85-119
21. Hirota, K.; Monguchi, Y.; Sajiki, H. Synthesis of Purine Acyclonucleosides via Ribofuranose-Ring Cleavage of Purine Nucleosides by Diisobutylaluminum Hydride. In: Recent Advances in Nucleosides. Chu, C.K., Ed., 2002, pp. 57-70
22. El Ashry, E.S.H.; Rashed, N. Carbohydrate Hydrazones and Osazones as Organic Raw Materials for Nucleosides and Heterocycles. Curr. Org. Chem., 2000, 4, 609-651
23. Littler, E.; Zhou, X.-X. In: Comprehensive Medicinal Chemistry II. Taylor, J.B.; Triggle, D.J., Eds., Elsevier, 2006, 7, pp. 295-327
24. Wedemeyer, H.; Hardtke, S.; Cornberg, M. Thera- pie der Hepatitis C – Aktuelle Standards und zu- künftige Entwicklungen. Chemother. J., 2012, 21, 1-7
25. Elgemeie, G.H.; Zaghary, W.A.; Amin, K.M.; Nasr, T.M. New trends in synthesis of pyrazole nucleosides as new antimetabolites. Nucleosides Nucleotides Nucleic Acids, 2005, 24, 1227-1247
26. Mironiuk-Puchalska, E; Koszytkowska-Stawinska, M.; Sas, W.; De Clercq, E.; Naesens, L. Synthesis of novel aza-analogues of tia zofurin with 2-[5,5-bis(hydroxymethyl)pyrrolidin-2-yl] framework as sugar mimic. Nucleosides Nucleotides Nucleic Acids, 2012, 31, 72-84
27. Merino, P.; Tejero, T.; Unzurrunzaga, F.J.; Franco, S., Chiacchio, U., Saita, M.G., Iannazzo, D., Piperno, A., Romeo, G. An efficient approach to enantiomeric isoxazolidinyl analogues of tiazofurin based on nitrone cycloadditions. Tetrahedron: Asimmetry, 2005, 16, 3865-3876
28. Chiacchio, U.; Rescifina, A.; Saita M.G.; Iannazzo, D.; Romeo, G.; Mates, J.A.; Tejero, T.; Merino, P. Zinc(II) triflate-controlled 1,3-dipolar cycloadditions of C-(2- thiazolyl)nitrones: application to the synthesis of a novel isoxazolidinyl analogue of tiazofurin. J. Org. Chem., 2005, 70, 8991-9001
29. Franchetti, P.; Cappellacci, L.; Perlini, P.; Jayaram, H.N.; Butler, A.; Schneider, B.P.; Collart, F.R.; Huberman, E.; Grifantini, M. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors. J. Med. Chem., 1998, 41, 1702-1707
30. Franchetti, P.; Cappellacci, L.; Marchetti, S.; Martini, C.; Costa, B.; Varani, K.; Borea, P.A.; Grifantini, M. C-nucleoside analogues of furanfurin as ligands to A1 adenosine receptors. Bioorg. Med. Chem., 2000, 8, 2367-2373
31. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Procopio, A.; Rescifina, A.; Romeo, G.; Romeo, R. A Stereoselective Approach to Isoxazolidinyl Nucleosides. Eur. J. Org. Chem., 2001, 10, 1893-1898
32. Chiacchio, U.; Corsaro, A.; Pistarà, V.; Rescifina, A.; Iannazzo, D.; Piperno, A.; Romeo, G.; Romeo, R.; Grassi, G. Diastereoselective Synthesis of N,O-Psiconucleosides, a New Class of Modified Nucleosides. Eur. J. Org. Chem., 2002, 7, 1206-1212
33. Saita, M.G.; Chiacchio, U.; Iannazzo, D.; Corsaro, A.; Merino, P.; Piperno, A.; Previtera, T.; Rescifina, A.; Romeo, G.; Romeo, R. Diastereo- and enantioselective synthesis of 1'-C-branched N,Onucleosides. Nucleosides Nucleotides Nucleic Acids, 2003, 22, 739-742
34. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Pistarà, V.; Rescifina, A.; Romeo, R.; Sindona, G.; Romeo, G. Diastereo- and enantioselective synthesis of N,O-nucleosides. Tetrahedron Asymmetry, 2003, 14, 2717-2723
35. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Pistarà, V.; Rescifina, A.; Romeo, R.; Valveri, V.; Mastino, A.; Romeo, G. Enantioselective syntheses and cytotoxicity of N,O-nucleosides. J. Med. Chem., 2003, 46, 3696-3702
36. Chiacchio, U.; Corsaro, A.; Mates, J.; Merino, P.; Piperno, A.; Rescifina, A.; Romeo, G.; Romeo, R.; Tejero, T. Erythropoiesis from acetyl LDL incorporating endothelial cells at the preliver stage. Tetrahedron, 2003, 59, 4733-4738
37. Chiacchio, U.; Genovese, F.; Iannazzo, D.; Librando, V.; Merino, P.; Rescifina, A.; Romeo, R.; Procopio, A.; Romeo, G. Diastereoselective synthesis of homo-N,O-nucleosides. Tetrahedron, 2004, 60, 441-448
38. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Romeo, G.; Romeo, R.; Saita, M.G.; Rescifina, A. Synthesis of Methyleneisoxazolidine Nucleoside Analogues by Microwave- Assisted Nitrone Cycloaddition. Eur. J. Org. Chem., 2007, 28, 4758-4764
39. Merino, P.; Tejero, T.; Matés, J.; Chiacchio, U.; Corsaro, A.; Romeo, G. 3-(Aminomethyl)-2-(carboxymethyl) isoxazolidinyl nucleosides: building blocks for peptide nucleic acid analogues. Tetrahedron Asymmetry, 2007, 18, 1517-1520
40. Romeo, G.; Giofré, S.V.; Piperno, A.; Romeo, R.; Chiacchio, M.A. Synthesis of N,O- homonucleosides with high conformational freedom. Arkivoc, 2009, (viii), 168-176
41. Romeo, R.; Giofrè, S.V.; Iaria, D.; Sciortino, M.T.; Ronsisvalle, S.; Chiacchio, M.A.; Scala, A. Synthesis of 5-Alkynyl Isoxazolidinyl Nucleosides. Eur. J. Org. Chem., 2011, 5690-5695
42. Romeo, R.; Giofrè, S.V.; Macchi, B.; Balestrieri, E.; Mastino, A.; Merino, P.; Carnovale, C.; Romeo, G.; Chiacchio, U. Truncated Reverse Isoxazolidinyl Nucleosides: A New Class of Allosteric HIV-1 Reverse Transcriptase Inhibitors. ChemMedChem, 2012, 7, 565-569
43. Romeo, R.; Giofrè, S.V.; Garozzo, A.; Bisignano, B.; Corsaro, A.; Chiacchio, M.A. Synthesis and biological evaluation of furopyrimidine N,O-nucleosides. Bioorg. Med. Chem., 2013, 21, 5688-5693
44. Romeo, R.; Giofrè, S.V.; Carnovale, C.; Campisi, A.; Parenti, R.; Bandini, L.; Chiacchio, M.A. Synthesis and biological evaluation of 3- hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines. Bioorg. Med. Chem., 2013, 21, 7929-7937
45. Romeo, R.; Giofrè, S.V.; Carnovale, C.; Chiacchio, M.A.; Campisi, A.; Mancuso, R.; Cirmi S.; Navarra, M. Synthesis and Biological Activity of Triazole-Appended N,O-Nucleosides. Eur. J. Org. Chem., 2014, 25, 5442-5447
46. Romeo, R.; Carnovale, C.; Giofrè, S.V.; Chiacchio, M.A.; Garozzo, A.; Amata, E.; Romeo, G.; Chiacchio, U. C-5'-Triazolyl-2'-oxa-3'- aza-4'a-carbanucleosides: Synthesis and biological evaluation. Beilstein Journal of Organic Chemistry, 2015, 11, 328-334
47. Giofrè, S.V; Romeo, R.; Carnovale, C.; Mancuso, R.; Cirmi, S.; Navarra, M.; Garozzo, A.; Chiacchio, M.A. Synthesis and biological properties of 5-(1H-1,2,3-Triazol-4-yl)isoxazolidines: A New Class of C-Nucleosides. Molecules. 2015, 20, 5260-5275
48. De Clercq, E.; Neyts, J.; Hand B. Antiviral agents acting as DNA or RNA chain terminators. Exp. Pharmacol., 2009, 189, 53-84
49. Berdis, A. DNA polymerases as therapeutic targets. J. Biochem., 2008, 47, 8253-8260
50. Hutter M.C.; Helms V. The mechanism of phosphorylation of natural nucleosides and anti-HIV analogues by nucleoside diphosphate kinase is independent of their sugar substituents. Chem. Biol. Chem., 2002, 3, 643-651
51. Schneider B.; Sarfati R.; Deville-Bonne D.; Veron M.J. Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs. Bioenerg. Biomembr., 2000, 32, 317-324
52. Stein, D.S.; Moore, K.H.P. Biological and mechanical properties of PMMA-based bioactive bone cements. Pharmacotherapy, 2001, 2137-2146;
53. Lascu, I.; Gonin, P.J. The catalytic mechanism of nucleoside diphosphate kinases. Bioenerg. Biomembr., 2000, 32, 237-246
54. Miller W.H.; Miller R.L. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. J. Biol. Chem., 1980, 25, 7204-7207;
55. Miller W.H.; Miller R.L. Phosphorylation of acyclovir diphosphate by cellular enzymes. Biochem. Pharmacol., 1982, 31, 3879-3884
56. Campbell, N.A.; Brad, W.; Robin, J. Heyden, Biology: Exploring life, Boston, Massachussetts: Pearson Prentice Hall, 2006
57. Mulato, A.S.; Cherrington, J.M. Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses. Antiviral Res., 1997, 36, 91-97
58. De Clercq, E.; Holy, A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Res. Drug Discov., 2005, 4, 928-940;
59. Deville-Bonne, D.; El Amri, C.; Meyer, P.; Chen, Y.X.; Agrofoglio, L.A.; Janin, J. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: structural and catalytic properties. J. Antiviral Res., 2010, 86, 101-120;
60. De Clercq, E. Antiviral drug discovery: ten more compounds, and ten more stories (part B). Med. Res. Rev., 2009, 29, 571-610;
61. De Clercq, E. In search of a selective therapy of viral infections. Antiviral Res., 2010, 85, 19-24
62. De Clercq, E. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond. Biochem. Pharmacol., 2011, 82, 99-109
63. De Clercq, R. Advances in Antiviral Drug Design. JAI Press: Greenwich, CT, 1995
64. Chiacchio, U.; Iannazzo, D.; Piperno, A.; Romeo, R.; Romeo, G.; Rescifina, A.; Saglimbeni, M. Synthesis and biological evaluation of phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides. Bioorg. Med. Chem., 2006, 14, 955-959
65. Chiacchio, U.; Balestrieri, M.; Macchi, B.; Iannazzo, D.; Piperno, A.; Rescifina, A.; Saglimbeni, M.; Sciortino M.T.; Valveri, V.; Mastino, A.; Romeo, G. Synthesis of phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides: novel inhibitors of reverse transcriptase. J. Med. Chem., 2005, 48, 1389-1394
66. Chiacchio, U.; Rescifina, A.; Iannazzo, D.; Piperno, A.; Romeo, R.; Borrello, L.; Sciortino, M.T.; Balestrieri, E.; Macchi, B.; Mastino, A.; Romeo, G. Phosphonated carbocyclic 2'-oxa-3'-azanucleosides as new antiretroviral agents. J. Med. Chem., 2007, 50, 3747-3750
67. Romeo, R.; Carnovale, C.; Giofrè, S.V.; Monciino, G.; Chiacchio, M.A.; Sanfilippo, C.; Macchi, B. Enantiomerically pure phosphonated carbocyclic 2'-oxa-3'-azanucleosides: synthesis and biological evaluation. Molecules, 2014, 19, 14406-14416
68. Piperno, A.; Giofrè, S.V.; Iannazzo, D.; Romeo, R.; Romeo, G.; Chiacchio, U.; Rescifina, A.; Piotrowska, D.G. Synthesis of C- 4'truncated phosphonated carbocyclic 2'-oxa-3'-azanucleosides as antiviral agents. J. Org. Chem., 2010, 75, 2798-2805
69. Romeo, R.; Romeo, G.; Carnovale, C.; Giofrè, S.V.; Macchi, B.; Frezza, C.; Merino-Merlo, F.; Pistarà, V.; Chiacchio, U. Truncated phosphonated C-1'-branched N,O-nucleosides: a new class of antiviral agents. Bioorg. Med. Chem., 2012, 20, 3652-3657
70. Vorbrüggen, J.M.; Kvolikiewicz, K.; Bennua, B. Nucleoside syntheses, XXII1 Nucleoside synthesis with trimethylsilyl triflate and perchlorate as catalysts. Chem. Ber., 1981, 114, 1234-1255
71. Sigel, H.; Griesser, R. Nucleoside 5_-triphosphates: self-association, acid–base, and metal ion-binding properties in solution. Chem. Soc. Rev. 2005, 34, 875-900
72. Sigel, H. Metal ion complexes of antivirally active nucleotide analogues. Conclusions regarding their biological action. Chem. Soc. Rev., 2004, 33, 191-200
73. Piotrowska, D.G.; Cieslak, M.; Krolewska, K.; Wroblewski, A.E. Design, synthesis and cytotoxicity of a new series of isoxazolidines derived from substituted chalcones. Eur. J. Med. Chem., 2011, 46, 1382-1389;
74. Grabkowska-Druzyc, M.; Balzarini, J.; Piotrowska, D.G. Design, synthesis, antiviral, and cytostatic evaluation of novel isoxazolidine analogues of C-nucleotides. Nucleosides Nucleotides Nucleic Acids, 2013, 32, 682-699
75. Gotkowska, J.; Balzarini, J.; Piotrowska, D.G. Synthesis of novel isoxazolidine analogues of homonucleosides. Tetrahedron Lett., 2012, 53, 7097-7100
76. Łysakowska, M.; Balzarini, J.; Piotrowska, D.G. Design, Synthesis, Antiviral, and Cytostatic Evaluation of Novel Isoxazolidine Analogs of Homonucleotides. Arch. Pharm. Chem. Life Sci., 2014, 347, 341-353
77. Piotrowska, D.G.; Cieslak, M.; Królewska, K.; Wróblewski, A.E. Design, synthesis and cytotoxicity of a new series of isoxazolidines derived from substituted chalcones. Eur. J. Med Chem., 2011, 46, 1382-1389
78. Kokosza, K.; Balzarini, J.; Piotrowska, D.G. Design, synthesis, antiviral and cytostatic evaluation of novel isoxazolidine nucleotide analogues with a carbamoyl linker. Bioorg. Med. Chem., 2013, 21, 1097-1108
79. Kokosza, K.; Balzarini, J.; Piotrowska, D.G. Novel 5-Arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as Nucleotide Analogues. Nucleosides Nucleotides Nucleic Acids, 2014, 33, 552-582
80. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes. Angew. Chem. Int. Ed., 2002, 41, 2596-2599.
81. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed., 2001, 40, 2004-2021
82. Fernandez, F.; Garcia-Mera, X.; Rodriguez, G.; Urrutia, A. New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors. Chem. Pharm. Bull., 1999, 47, 1006.